XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Income and Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Product revenue $ 20,563 $ 11,200 $ 64,503 $ 22,105
Cost of goods sold (2,624) (1,640) (8,787) (4,062)
Gross profit 17,939 9,560 55,716 18,043
Operating expenses:        
Research and development expenses 7,986 3,866 19,875 10,960
Selling, general and administrative expenses 10,341 6,953 32,997 22,532
Total operating expenses 18,327 10,819 52,872 33,492
Operating income (loss) (388) (1,259) 2,844 (15,449)
Change in fair value of warrant liability 0 2,975 0 (7,392)
Interest income (expense), net 796 113 2,063 (170)
Other income (expense) (33) 35 (63) 23
Income (loss) before income taxes 375 1,864 4,844 (22,988)
Income tax (benefit) expense (455) 0 248 0
Net income (loss) 830 1,864 4,596 (22,988)
Other comprehensive income (loss):        
Unrealized gain on investments adjustments 296 (14) 592 (147)
Foreign currency translation adjustments (13) 17 201 23
Total comprehensive income (loss) $ 1,113 $ 1,867 $ 5,389 $ (23,112)
Common share data:        
Basic income (loss) per common share (in dollars per share) $ 0.02 $ 0.06 $ 0.13 $ (0.84)
Weighted average number of basic shares outstanding (in shares) 36,383,277 28,738,307 35,610,619 27,335,212
Diluted income (loss) per common share (in dollars per share) $ 0.02 $ 0.06 $ 0.12 $ (0.84)
Weighted average number of diluted shares outstanding (in shares) 40,056,814 32,345,672 39,949,941 27,335,212